AB0252 RACIAL DISPARITIES IN OUTCOMES FOR PATIENTS WITH RHEUMATOID ARTHRITIS UNDERGOING TOTAL KNEE OR TOTAL HIP ARTHROPLASTY. (June 2019)
- Record Type:
- Journal Article
- Title:
- AB0252 RACIAL DISPARITIES IN OUTCOMES FOR PATIENTS WITH RHEUMATOID ARTHRITIS UNDERGOING TOTAL KNEE OR TOTAL HIP ARTHROPLASTY. (June 2019)
- Main Title:
- AB0252 RACIAL DISPARITIES IN OUTCOMES FOR PATIENTS WITH RHEUMATOID ARTHRITIS UNDERGOING TOTAL KNEE OR TOTAL HIP ARTHROPLASTY
- Authors:
- Hirsch, Julianna
Mehta, Bella
Finik, Jackie
Mirza, Serene
Figgie, Mark
Brantner, Collin
Navarro-Millan, Iris
Goodman, Susan - Abstract:
- Abstract : Background: Race is linked to delays in healthcare. Black and Hispanic patients with osteoarthritis have worse pain and function than Whites before arthroplasty. Whether Black and Hispanic patients with RA similarly delay care is unknown. Objectives: To assess whether Black and/or Hispanic (minority) RA patients have worse pain, function and disease activity at the time of arthroplasty. Methods: We used prospectively acquired data on RA patients between 10/2013 and 11/2018 prior to total knee arthroplasty (TKA) or total hip arthroplasty (THA). Pain, function, and disease activity were assessed using the visual analogue scale (VAS), the Multidimensional Health Assessment Questionnaire (MD HAQ), and the Disease Activity Score (DAS28). Race, ethnicity, education, income, insurance and medications were collected via self-report questionnaire. Multivariable linear and logistic models examined whether minority status predicted pain, function and disease activity. Results: 37 (23%) of the 164 patients were minorities (Table 1 ). MD HAQ and DAS28 were worse in minorities, only VAS was significant (p-value= 0.029). There was no significant difference in education. Unadjusted comparisons indicated no difference in pain, function, disease activity or medication use between groups. Insurance varied significantly between groups (p= <0.0001). In the multivariable analyses (Table 2 ), minority status was not significantly associated with worse function (MD HAQ) [p=0.26], diseaseAbstract : Background: Race is linked to delays in healthcare. Black and Hispanic patients with osteoarthritis have worse pain and function than Whites before arthroplasty. Whether Black and Hispanic patients with RA similarly delay care is unknown. Objectives: To assess whether Black and/or Hispanic (minority) RA patients have worse pain, function and disease activity at the time of arthroplasty. Methods: We used prospectively acquired data on RA patients between 10/2013 and 11/2018 prior to total knee arthroplasty (TKA) or total hip arthroplasty (THA). Pain, function, and disease activity were assessed using the visual analogue scale (VAS), the Multidimensional Health Assessment Questionnaire (MD HAQ), and the Disease Activity Score (DAS28). Race, ethnicity, education, income, insurance and medications were collected via self-report questionnaire. Multivariable linear and logistic models examined whether minority status predicted pain, function and disease activity. Results: 37 (23%) of the 164 patients were minorities (Table 1 ). MD HAQ and DAS28 were worse in minorities, only VAS was significant (p-value= 0.029). There was no significant difference in education. Unadjusted comparisons indicated no difference in pain, function, disease activity or medication use between groups. Insurance varied significantly between groups (p= <0.0001). In the multivariable analyses (Table 2 ), minority status was not significantly associated with worse function (MD HAQ) [p=0.26], disease activity (DAS28-ESR) [p=0.658], or VAS pain [p=0.18]. Increased age was significantly associated with better function (p=0.004). Conclusion: For Black and/or Hispanics with RA undergoing THA or TKA at a high-volume specialty hospital, minority status was not significantly associated with pain, disability or RA disease activity at the time of elective arthroplasty. Disclosure of Interests: Julianna Hirsch: None declared, Bella Mehta: None declared, Jackie Finik: None declared, Serene Mirza: None declared, Mark Figgie: None declared, Collin Brantner: None declared, Iris Navarro-Millan: None declared, Susan Goodman Grant/research support from: Novartis: research support, Consultant for: Novartis, UCB, Pfizer: consulting … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 78(2019)Supplement 2
- Issue Display:
- Volume 78, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 78
- Issue:
- 2
- Issue Sort Value:
- 2019-0078-0002-0000
- Page Start:
- 1583
- Page End:
- 1583
- Publication Date:
- 2019-06
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2019-eular.4997 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19906.xml